Eloxx Pharmaceuticals (NASDAQ: ELOX) is doing good and interesting work. They're part of - for example - the current revolution in the treatment of cystic fibrosis. As they reported at the beginning of May they've FDA approval for a study on ZKN-013. But that's a very, very, early stage treatment, this is where it's given to healthy volunteers to see if there are any ill-effects of the treatment itself. It's nothing to do with whether it actually treats or cures anything. These Phase I trials have to be done but they're the very start of the near decade long process to - maybe - having something that can be sold on the market.
We'd not say that there's anything wrong with Eloxx therefore. Indeed we'd say that there's quite a lot right. They're working in a corner of pharma where we know that interesting things are happening. The wider drug development technology allows certain problems to be addressed that is. To use Terry Pratchett's phrase, it's steam engine time.
It's also true that the recent accounts don't show any gremlins. Matters are pretty much as they should be for a company at this stage of the development process. We'd thus say that Eloxx is a pretty good example of a pharma development company in fact. Huge risk attached to it - no one ever does know whether a treatment really will pan out until it actually does so - but then that's what the game is in this field.
However, what we can go on to say is that there's really no reason for a 200% jump in the ELOX stock price. Therefore we'd rather assume that it will come back down again.

Eloxx Pharmaceuticals stock price from NASDAQ.
As we can see from that stock price chart it already is coming back down. Intraday the rise was more like 400% after which it retreated 50%. Just from experience of observing small caps we'd say that the surge - that final doubling of the price to near $14 - was the result of a small amount of buying in those thin markets just after close. With the associated fallback as well.
There is no special news from the company to explain this price movement. What there is is a very small market capitalisation (some $7 million) being driven by a wave of activity and no more than that. The question really becomes whether someone is deliberately driving this - what is called a pump and dump - or whether it's just one of those things - a momentum trade perhaps. But given that there seems to be no objective reason for it we'd expect it not to persist.
As we say, there's nothing objectively wrong with Eloxx but it's not that darn good either. Therefore we expect the price to settle back down again.